✦ LIBER ✦

Soluble CD44 splice variants in metastasizing human breast cancer

✍ Scribed by Stephan Martin; Frank Jansen; Johannes Bokelmann; Hubert Kolb

Publisher: John Wiley and Sons
Year: 1997
Tongue: French
Weight: 58 KB
Volume: 74
Category: Article
ISSN: 0020-7136
DOI: 10.1002/(sici)1097-0215(19970822)74:4<443::aid-ijc14>3.0.co;2-a

No coin nor oath required. For personal study only.

✦ Synopsis

The local expression of CD44 splice variants in human breast cancer tissue has been previously shown to be associated with metastasis. We show here that elevated systemic serum levels of CD44 splice variants occur in breast cancer and may represent a new tool for staging and differential diagnosis. Sera of node-negative and node-positive breast cancer patients in comparison with healthy control subjects were analyzed for serum CD44 (sCD44) and 2 different splice variants (v5 and v6). Node-positive breast cancer patients showed significantly (p < 0.01) elevated levels of sCD44-v5 and -v6 splice variants in comparison to node-negative patients and healthy controls. None of the node-negative breast cancer patients or healthy controls showed elevated levels of both sCD44-v5 and -v6. Interestingly, no differences were seen for serum levels of non-spliced sCD44-standard between the 3 groups. Soluble forms of CD44 variants may promote migration of tumor cells. This may occur through interference with tumor cell adhesion or by modulation of immune defense mechanisms.

📜 SIMILAR VOLUMES

Immunohistochemical detection of adhesio

Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer

✍ Christian Kainz; Clemens Tempfer; Petra Kohlberger; Seline Janisch; Heinz Koelbi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 French ⚖ 446 KB

Expression of specific cell adhesion molecule CD44 isoforms (splice variants) has been shown to be associated with poor prognosis in human cervical cancer. We used 3 different variant exon sequence-specific murine monoclonal antibodies (MAbs) to epitopes encoded by exons v5, v6 and v7-v8 of human va

Prognostic value of CD44 variant express

Prognostic value of CD44 variant expression in primary breast cancer

✍ John A. Foekens; Peter Dall; Jan G.M. Klijn; Petra Skroch-Angel; Cassandra J.C. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 243 KB 👁 2 views

CD44 is a family of cell surface transmembrane glycoproteins members which differ in the extracellular part by sequences derived by alternative splicing of 10 variant exons (v1-v10). CD44 proteins containing such variant sequences have been implicated in tumor metastasis formation. Here, we have eva

Soluble CD44 variants in serum of patien

Soluble CD44 variants in serum of patients with prostate cancer and other urological malignancies

✍ Lein, Michael; Weiβ, Susanne; Jung, Klaus; Schnorr, Dietmar; Loening, Stefan 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

In a recent paper published in this journal [l], the authors measured the expression of CD44 isoforms in four human prostate tumor cell lines by flow cytometric analysis, Western blot, and at the mRNA level by reverse transcription polymerase chain reaction. The results showed that CD44 isoforms wer

Identification of an exon 3 deletion spl

Identification of an exon 3 deletion splice variant androgen receptor mRNA in human breast cancer

✍ Xiang Zhu; Angela A.I. Daffada; Christina M.W. Chan; Mitchell Dowsett 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 241 KB 👁 2 views

Androgens and androgen receptor (AR) are involved in many regulatory processes in the growth of female breast cells. Mutations in the AR gene and/or alterations of the AR protein sequence may be related to the development and progression of breast cancer. Using reverse transcriptionpolymerase chain

Human tenascin-C: Identification of a no

Human tenascin-C: Identification of a novel type III repeat in oral cancer and of novel splice variants in normal, malignant and reactive oral mucosae

✍ Alan J. Mighell; John Thompson; William J. Hume; Alexander F. Markham; Philip A. 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 121 KB

Tenascin-C is a mosaic, linear glycoprotein that is upregulated during many normal and pathological processes involving either cell migration or tissue morphogenesis, such as invasion of malignant cells and wound healing. Human tenascin-C contains 8 consecutive type III fibronectin (TNCfn) domains t

Immunological characterization of cell-s

Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts

✍ Hui Li; Delbert E. Bauzon; Xinyun Xu; Harald Tschesche; Jian Cao; QingXiang Amy 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 242 KB 👁 1 views

Membrane type (MT) 1 matrix metalloproteinase (MMP) activates progelatinase A (pro-MMP-2), a type IV collagenase, on the cell surface of tumors; however, its function in breast cancer progression and metastasis is not fully understood. To examine the expression of MT1-MMP in breast cancer cells and